FMP

FMP

Enter

TELA - TELA Bio, Inc.

Profile of TELA Bio, Inc.(TELA), TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reco

About

ceo

Mr. Antony Koblish

sector

Healthcare

industry

Medical - Devices

website

https://www.telabio.com

exchange

NASDAQ

Description

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. The company markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

CIK

0001561921

ISIN

US8723811084

CUSIP

872381108

Address

1 Great Valley Parkway

Phone

484 320 2930

Country

US

Employee

227

IPO Date

Nov 8, 2019

Key Executives

page loading card
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep